Dyne Therapeutics: Moving Forward On 2 Key Fronts
Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...
News Medical13 小时
Decades of DNA expansion linked to Huntington’s disease neurodegeneration
A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...